64. In regulation 87 (post authorisation requirements in relation to UK marketing authorisations with paediatric aspects and advanced therapy medicinal products), in the inserted regulation 78B (post authorisation requirements in relation to UK marketing authorisations for advanced therapy medicinal products)—U.K.
(a)in the heading to the regulation for “UK marketing authorisations” substitute “ UKMA(GB) ”;
(b)for “UK marketing authorisation” in each place it appears substitute “ UKMA(GB) ”.
Commencement Information
I1Sch. 2 para. 64 in force at 31.12.2020 immediately before IP completion day, see reg. 1